NanoString Technologies Obtains $20,000,000 Series D Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=84c5cb27-07b3-4cb4-964b-f233640ca18f&Preview=1 -
Date
11/7/2011 -
Company Name
NanoString Technologies -
Mailing Address
530 Fairview Ave N Seattle, WA 98109 -
Company Description
NanoString Technologies is developing a patent pending platform for single molecule identification and digital quantification. The NanoString system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample. -
Website
http://www.nanostring.com -
Transaction Type
Venture Equity -
Transaction Amount
$20,000,000 -
Transaction Round
Series D -
Proceeds Purposes
The proceeds of the financing will be used to continue the growth of NanoString’s life science tools business, as well as advance the development of the company’s first molecular diagnostic product, a breast cancer assay based on the PAM50 gene expression signature. -
M&A Terms
-
Venture Investor
GE Healthare Financial Services -
Venture Investor
Individual Investor -
Venture Investor
Clarus Ventures -
Venture Investor
Draper Fisher Jurvetson -
Venture Investor
OVP Venture Partners
